Posted on July 23rd, 2010
A woman in Georgia has filed a lawsuit claiming to have been harmed by her prescription of a generic version of the drug Reglan.
According to court documents, Susan Swicegood claims a generic brand of Reglan caused her to contract a rare neurological disorder – tardive dyskinesia. Pharmaceutical company Pliva is accused of not including warnings about tardive dyskinesia in the medical reference book, Physician’s Desk Reference. Swicegood claims the lack of this crucial information about possible side effects prevented her and her doctor from making an informed decision about her treatment.
Reglan, also labeld as generic metoclopramide, provides relief from gastrointestinal problems like delayed gastric emptying, diabetic gastroparesis, and gastroesophageal reflux (GERD). The FDA ordered makers of the drug to add a black box warning about tardive dyskinesia in the last year.
For sound legal advice and assistance regarding Reglan side-effects and injury liability, please contact the Reglan Tardive Dyskinesia lawyers of Williams Kherkher today at 800-781-3955.
Posted on July 16th, 2010
Two parents, Joshua and Lindsey Whitener, are suing the makers of the heartburn drug Reglan for supposedly causing birth defects in their child.
Lindsey Whitener was prescribed Reglan for morning sickness when she was seven weeks pregnant with their son. She alleges her doctor told her the medication was safe and did not warn her of the possibility of harmful side-effects to her unborn child. Whitener took Reglan for four weeks.
The Whitener’s son was born prematurely at 36 weeks with serious physical disabilities and had to spend the first six months of his life in the hospital. Doctors told her they were unsure of what caused their son’s problems.
Lindsey Whitener became suspicious a year later after seeing a commercial about Reglan’s negative side effects on TV.
If you or someone you love has been negatively affected by the heartburn medication Reglan, contact the Reglan lawsuit attorneys of Williams Kherkher at 800-761-3187 to learn more about your rights.
Posted on July 9th, 2010
Another lawsuit against the maker of the drug Reglan was filed in June, according to court documents.
The newest lawsuit was filed by Israel Bennet, who claims he was prescribed the drug reglan to treat Gastroesophageal Reflux Disease. Bennett says he took the drug regularly for almost five months until he was diagnosed with Tardive Dyskensia. The lawsuit contends that the drug’s manufacturer did not provide him with the right details of the Reglan drug on a long-term basis, and actually provided incorrect and disingenuous information.
Tardive Dyskinesia is a movement disorder characterized by painful and uncontrolled movement of the facial muscles and extremities. Symptoms often include unintentional lip smacking, grimacing, and lip puckering.
If you or a loved one has become ill after use Reglan, contact the Reglan Tardive Dyskinesia attorney of Williams Kherkher by calling 800-761-3187.
Posted on July 8th, 2010
The United States Food and Drug Administration recently required the makers of the drug Reglan to include a black box warning about Tardive Dyskinesia.
A black box warning, also known as a black label warning or a boxed warning, is a type of warning that appears on the package insert for prescription drugs that can cause serious adverse effects. The name comes from the black border that usually surrounds the text of the warning.
A black box warning means that medical studies indicate that the drug carries a significant and substantial risk of serious or life-threatening adverse effects. The U.S. Food and Drug Administration can require a pharmaceutical company to place a boxed warning on the labeling of a prescription drug or any literature detailing it. It is the strongest warning the FDA requires.
The FDA has linked use of the drug Reglan to the debilitating and incurable movement disorder Tardive Dyskensia. For sound legal advice and assistance regarding Reglan side-effects and injury liability, please contact the Reglan Tardive Dyskinesia lawyers of Williams Kherkher today at 800-781-3955.
Posted on July 2nd, 2010
The ever-growing number of lawsuits filed against the manufacturer of the drug Reglan is at the center of debate over whether drug companies are immune from court action at the state level if their products are federally regulated.
There has been ongoing debate about whether generic drug makers are liable for side effects caused by their medications. The drug companies argue that the United States Food and Drug Administration’s mandate that generic drugs carry the same warning labels as their name brand counterparts relieves them of responsibility. This question is the focus of a lawsuit in Cincinnati, Ohio.
A court in Ohio ruled that generic drug maker was not responsible for the Tardive Dyskinesia a man developed after taking a generic form of Reglan. An appeals court is reconsidering the lawsuit and has requested the FDA provide its stance on this label issue, asking that an answer be delivered by July 29.
If you or someone you love has suffered from averse side-effects due to the prescription drug Reglan, call the Reglan tardive dyskinesia attorneys of Williams Kherkher at 800-781-3955 today.
Posted on July 2nd, 2010
It has been more than twenty years since the first Reglan tardive dyskinesia lawsuit was filed, and new lawsuits continue to be brought against the drugs manufacturers.
Reglan, which is also known as generic metrocrlopramide, is a drug approved for the short-term treatment of gastrointestinal disorders. Designed for temporary treatment of diabetic gastroparesis, gastroesophageal reflux (GERD) and delayed gastric emptying, but the dug is often prescribed for longer periods of time. Long-term use of the drug has been shown to greatly increase the risk of tardive dyskinesia in patients.
Tardive dyskinesia is a neurological movement disorder. The disorder causes repetitive and involuntary movement of the face and extremities. Involuntary grimacing, chewing, smacking or pursing of the lips, rapid eye movements and impaired finger movements are common manifestations of the disorder.
If you or a loved one has become ill after use Reglan, contact the Reglan lawsuit attorney of Williams Kherkher by calling 800-761-3187.
Posted on June 25th, 2010
A man from Jefferson Parish, Louisiana is suing the manufacturer of a reflux medicine claiming the drug is to blame for his nervous system disorder.
Isreal Bennett filed a lawsuit in the Federal Court of New Orleans against Qualitest Pharmaceuticals earlier this month. Bennett says he was prescribed the drug Reglan to treat reflux from December 2008 through May 2009. The lawsuit claims he was later diagnosed with tardive dyskensia, a disorder that affects the nervous system and causes uncontrollable muscle movements. Bennett claims that the drug caused serious and permanent injury to his central nervous system and extrapyramidal motor system.
The lawsuit contends that Qualitest Pharmaceuticals provided inaccurate, misleading, incomplete, false and otherwise inadequate information concerning the side effects of long-term exposure to Reglan. Bennett is seeking damages for medical expenses, physical pain and suffering, mental anguish, physical disfigurement, physical impairment, loss of earnings, loss of earning capacity, court costs and interest.
If you have developed tardive dyskinesia after using the drug Reglan, you may be eligible for compensation from pharmaceutical companies. Contact the Reglan lawsuit attorneys of Williams Kherkher at 800-761-3187 today to discuss your rights and options.
Posted on June 18th, 2010
Neurocrine Biosciences, a California-based pharmaceutical firm, has announced an intention to press their tardive dyskinesia treatment into US trials under the federal Food & Drug Administration’s Investigational New Drug program.
A previous trial taken up in Canada among healthy male volunteer candidates offered positive feedback, showing no major negative reactions to the drug treatment, including no substantially abnormal ECG findings. The company characterized the drug’s performance in these first phase tests as well-tolerated and working toward its primary function.
The treatment process inhibits brain chemicals that off-set the levels of dopamine that the brain receives in communications between nerves. Neurocrine notes that this drug also marginalizes any change to other monoamines in the brain, which otherwise could have increased side-effects.
This drug has been offered to the public as a possible treatment for not only tardive dyskinesia, but similar disorders like Tourette’s syndrome and even some forms of schizophrenia.
If you have developed tardive dyskinesia after using the drug Reglan, you may be eligible for compensation from pharmaceutical companies. Contact the Reglan lawsuit attorneys of Williams Kherkher at 800-761-3187 today to discuss your rights and options.
Posted on June 16th, 2010
Since the past year, a black box warning label has marked Reglan as one of the most dangerous prescription drugs on the market. However, the label does not address studies that prove that Reglan does not even live up to its expectations as an effective drug.
The Food & Drug Administration originally approved Reglan in 1979 to combat gastrointestinal problems, especially gastroparesis and gastroesophageal reflex disease. While it took 30 years to issue the black box label to warn patients about possible complications, it did not take 30 years to publish a study to prove that the drug had minimal effectiveness to match its dangerousness.
Studies published in 1975, 1983, and 2006 all pointed to weak or non-existent responses to the drug treatment. In comparison, 1983, 1984, and 1992 saw studies pointing out the risks of Reglan.
Reglan is only supposed to be taken for short-term treatment of gastrointestinal ailments, but has been proven to be ineffective for many of the most needy patients suffering from these disorders.
If you or someone you love has been diagnosed with tardive dyskinesia due to Reglan use, you may be entitled to compensation for your medical bills and suffering. Contact the Reglan tardive dyskenesia lawsuit attorneys of Williams Kherkher today by calling 800-761-3187.
Posted on June 11th, 2010
According to a Louisiana mother, the drug Reglan was responsible for birth defects in her child.
The mother has filed a suit against the manufacturer of the drug, Pliva, Inc. She complained of nausea and vomiting to her doctor, who prescribed Reglan during her seventh week of pregnancy. She took the medicine for roughly four weeks. Around week 32, she complained to her doctor, which was followed by the birth of her son in week 36. The premature birth led to numerous complications that baffled medical staff.
The suit complaint includes charges of multiple emotional complications, permanent disabilities, medical expenses, lost wages, and other financial deficiencies.
The woman claimed that she was unaware of problems with the medication until she saw an advertisement including the side-effects on the television. The medication is not supposed to be prescribed for pregnant mothers, and has been given the Food & Drug Administration’s strongest warning label due to multiple reports of adverse effects.
If you too have been affected by Reglan, you may be entitled to compensation for your suffering. Contact the Reglan side effect attorneys of Williams Kherkher by calling 800-761-3187 today to discuss your claim and possible options.
